Company Filing History:
Years Active: 1988
Title: Dov Kanner: Innovator in Biotechnology
Introduction
Dov Kanner is a prominent inventor based in Rehovot, Israel. He has made significant contributions to the field of biotechnology, particularly in the production of high molecular weight sodium hyaluronate. His innovative work has led to the development of novel microorganisms that enhance the efficiency of hyaluronic acid production.
Latest Patents
Dov Kanner holds 3 patents related to his groundbreaking research. His latest patents focus on a novel mutant microorganism, Streptococcus zooepidemicus HA-116 ATCC 39920, which produces large amounts of high molecular weight hyaluronic acid. The invention outlines a method for obtaining such microorganisms and details a process for producing sodium hyaluronate. This process involves growing the microorganism in a nutrient medium with a sugar component as a carbon source, maintaining specific conditions for pH and magnesium ion concentration. The resulting sodium hyaluronate is characterized by its absence of pyrogenicity and skin irritation, making it suitable for various applications.
Career Highlights
Dov Kanner has established himself as a key figure in the biotechnology sector. He works at Bio-Technology General Corporation, where he continues to innovate and develop new methods for producing essential biochemicals. His expertise in microbial biotechnology has positioned him as a leader in his field.
Collaborations
Throughout his career, Dov Kanner has collaborated with notable colleagues, including Abraham Nimrod and Benjamin Greenman. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Dov Kanner's contributions to biotechnology, particularly in the production of high molecular weight sodium hyaluronate, highlight his role as an influential inventor. His work continues to impact the industry positively, paving the way for future advancements.